600+ sources. One page. See who else covered it.
Chinese biopharmaceutical developer IASO Biotechnology completed the full acquisition of Singapore based immune cell engineering firm MediSix Therapeutics on 13 August 2026 to expand cellular therapy capabilities
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Warning: this article contains spoilers After six episodes of slowly bringing its two timelines closer together, Silo season three finally offers one of its clearest glimpses yet of how the world…
JOHANNESBURG: South Africa’s rand was little changed on Friday as easing US inflation boosted speculation the Federal Reserve would keep rates on hold, while Middle East tensions supported the dollar.
Syria and Iraq have agreed to form judicial committees to oversee the cases of ISIS prisoners who were transferred from Syrian detention facilities to Iraqi prisons this year.
[SINGAPORE] Singapore and dozens of other countries are at risk of being used by Chinese exporters to avoid US tariffs, President Donald Trump’s...
[SINGAPORE] Singapore and dozens of other economies are at risk of being used by Chinese exporters to avoid US tariffs, President Donald Trump’s...
As the market share of electric vehicles (EVs) on the road grows, the gas tax’s ability to fund road projects and decrease traffic congestion erodes.